Reusable Pen Injector Market Report 2026

Reusable Pen Injector Market Overview

• Reusable Pen Injector market size has reached to $4.46 billion in 2025 • Expected to grow to $6.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: The Increasing Prevalence Of Diabetes Is Driving The Market Due To Rising Demand For Convenient Insulin Administration • Market Trend: Reusable Multi-Dose Injection Devices Advancing Affordable Chronic Disease Treatment Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Reusable Pen Injector Market?

A reusable pen injector is a durable, manually operated drug delivery device designed for repeated administration of precise doses of injectable medications through replaceable cartridges and detachable needles, offering controlled dosing, improved handling, and enhanced convenience for long-term therapeutic management while reducing material waste compared to single-use injection systems. These devices are widely utilized in the management of chronic and self-administered therapies across healthcare settings, supporting patient adherence, dose accuracy, portability, and efficient medication administration in both clinical and home-based treatment environments. The main product types of reusable pen injector include manual reusable pen injectors and smart reusable pen injectors. Manual reusable pen injectors refer to injection devices designed for repeated use that allow patients to administer precise doses of medication through replaceable cartridges. These products are made using materials such as plastic, metal, glass, and combination materials. They find application in diabetes management, hormonal therapies, anaphylaxis treatment, chronic diseases, and vaccination, serving end users including hospitals and clinics, home care settings, pharmaceutical companies, research institutions, and academic and training institutions.

What Is The Reusable Pen Injector Market Growth Forecast?

The reusable pen injector market size is expected to see strong growth in the next few years. It will grow to $6.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth of smart connected injector ecosystems, expansion of home based healthcare delivery models, integration of digital dose tracking and analytics, rising adoption of biologics and biosimilar injectable therapies, increasing demand for sustainable and reusable medical devices. Major trends in the forecast period include smart reusable pen injectors with dose tracking integration, increasing adoption of home-based self-administration for chronic disease management, growing demand for cartridge-based modular drug delivery systems, rising focus on ergonomic and patient-centric injector designs, expansion of biologics and biosimilars requiring high-precision dosing devices.

Global Reusable Pen Injector Market Segmentation

1) By Product Type: Manual Reusable Pen Injectors; Smart Reusable Pen Injectors 2) By Material: Plastic; Metal; Glass; Combination Materials 3) By Application: Diabetes Management; Hormonal Therapies; Anaphylaxis Treatment; Chronic Diseases; Vaccination 4) By End User: Hospitals And Clinics; Home Care Settings; Pharmaceutical Companies; Research Institutions; Academic And Training Institutions Subsegments: 1) By Manual Reusable Pen Injectors: Spring Driven Manual Pen Injectors; Dial Dose Manual Pen Injectors; Push Button Manual Pen Injectors; Twist Dose Manual Pen Injectors 2) By Smart Reusable Pen Injectors: Bluetooth Enabled Smart Pen Injectors; Mobile Application Connected Smart Pen Injectors; Dose Tracking Smart Pen Injectors; Data Logging Smart Pen Injectors

What Is The Driver Of The Reusable Pen Injector Market?

The increasing prevalence of diabetes is expected to propel the growth of the reusable pen injector market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from insufficient insulin production or ineffective insulin utilization by the body. The prevalence of diabetes is increasing due to rising obesity rates, sedentary lifestyles, and aging populations, which collectively contribute to impaired glucose metabolism and higher disease incidence globally. Reusable pen injectors support diabetes management by enabling accurate, convenient, and repeatable self-administration of insulin and other injectable therapies, thereby improving long-term treatment adherence and glycemic control. For instance, in August 2023, according to the International Diabetes Federation (IDF), a Belgium-based nonprofit organization, an estimated 11.1% of adults aged 20–79 years, equivalent to 1 in 9 individuals, were living with diabetes in 2025, with more than 40% remaining undiagnosed, while projections indicate that by 2050 nearly 1 in 8 adults, or approximately 853 million people, will have the condition, representing a 46% increase. Therefore, the increasing prevalence of diabetes is driving the growth of the reusable pen injector industry.

Key Players In The Global Reusable Pen Injector Market

Major companies operating in the reusable pen injector market are Novo Nordisk AS; Eli Lilly and Company; Sanofi SA; SHL Medical AG; Ypsomed AG; Stevanato Group S.p.A; Becton Dickinson and Company; Gerresheimer AG; Medtronic plc; Nemera; Owen Mumford Ltd.; medmix AG; Embecta Corp.; AptarGroup Inc.; West Pharmaceutical Services Inc.; Biocon Limited; Duoject Medical Systems Inc.; Bespak; Lepu Medical Technology Beijing Co. Ltd.; Wockhardt Limited; GenSci Pharmaceutical Co. Ltd.; Jiangsu Delfu Medical Device Co. Ltd.; Credence MedSystems; Phillips-Medisize.

Global Reusable Pen Injector Market Trends and Insights

Major companies operating in the reusable pen injector market are focusing on developing innovative products, such as multi-dose injection pens to improve dosing flexibility, patient adherence, and cost-effective chronic disease management. A multi-dose injection pen is a reusable drug delivery device designed to administer multiple adjustable doses of injectable medication from replaceable or prefilled cartridges. For instance, in March 2026, Zydus Lifesciences Limited, an India-based global life sciences company, launched Semaglutide Injection, a reusable multi-dose pen device. The device enables patients and healthcare professionals to administer varying dose strengths from a single reusable pen, reducing dependence on multiple disposable injection systems during dose escalation therapy. The innovation enhances treatment accessibility and convenience while supporting improved adherence and lower long-term therapy costs for diabetes and obesity management.

What Are Latest Mergers And Acquisitions In The Reusable Pen Injector Market?

In May 2026, Embecta, a US-based provider of insulin delivery devices, pen needles, syringes, and diabetes care solutions, acquired Owen Mumford Holdings for $201 million. With this acquisition, Embecta aimed to expand beyond diabetes care by strengthening its injectable drug delivery capabilities and broadening its presence in autoimmune disease, biologics, and anaphylaxis treatment markets through Owen Mumford’s auto-injector platform and manufacturing expertise. Owen Mumford Holdings is a UK-based provider of auto-injectors, reusable insulin pen injectors, lancets, syringes, pen needles, and other self-injection and medical device solutions.

Regional Outlook

North America was the largest region in the reusable pen injector market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Reusable Pen Injector Market?

The reusable pen injector market consists of sales of cartridge-based drug delivery pens, adjustable-dose injection devices, and related accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Reusable Pen Injector Market Report 2026?

The reusable pen injector market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the reusable pen injector industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.